FDA approves AbbVie's Skyrizi for children with psoriatic disease
Go back to FDA approves AbbVie's Skyrizi for children with psoriatic disease| AbbVie (NYSE: ABBV) | Delayed: 262.51 -0.53 (0.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $263.04 | 52 Week High | $68.12 | |||
| Open | $261.99 | 52 Week Low | $50.71 | |||
| Day High | $264.00 | P/E | 56.94 | |||
| Day Low | $260.98 | EPS | $4.61 | |||
| Volume | 3,058,748 | |||||
